{"id":8075,"date":"2024-03-06T11:08:12","date_gmt":"2024-03-06T10:08:12","guid":{"rendered":"https:\/\/blog.caixaresearch.org\/?p=8075"},"modified":"2024-03-06T11:56:25","modified_gmt":"2024-03-06T10:56:25","slug":"programa-pioner-europa-acelerar-traslacio-investigacio-trip","status":"publish","type":"post","link":"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/","title":{"rendered":"Un programa pioner a Europa per acelerar la traslaci\u00f3 de la investigaci\u00f3 a la pr\u00e0ctica cl\u00ednica"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"Programa TRIP | Con la colaboraci\u00f3n de Fundaci\u00f3n &quot;la Caixa&quot;\" src=\"https:\/\/www.youtube.com\/embed\/ZN-J6WHYS8Y\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><span style=\"font-weight: 400;\">Un dels problemes de major complexitat en la investigaci\u00f3 biom\u00e8dica internacional \u00e9s com traslladar el coneixement generat als centres de recerca a la pr\u00e0ctica cl\u00ednica, i viceversa, de la forma m\u00e9s eficient i en el menor temps possible. Aquest proc\u00e9s, conegut com a \u201cinvestigaci\u00f3 translacional\u201d, s&#8217;ha assajat a tot el m\u00f3n amb f\u00f3rmules diverses, entre les quals s\u2019inclou empla\u00e7ar centres de recerca fonamental a hospitals per propiciar el contacte entre tots dos \u00e0mbits i el desenvolupament de projectes conjunts.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La innovadora proposta de l&#8217;IRB Barcelona, en el marc del <\/span><a href=\"https:\/\/www.irbbarcelona.org\/ca\/about-us\/projects-alliances\/translational-research-and-innovation-programme-trip\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">programa pilot TRIP (en angl\u00e8s, <\/span><i><span style=\"font-weight: 400;\">Translational Research Innovation Programme<\/span><\/i><span style=\"font-weight: 400;\">)<\/span><\/a><span style=\"font-weight: 400;\">, resideix en promocionar grups de recerca que estiguin liderats per, almenys, <\/span><b>un investigador fonamental i un professional m\u00e8dic que combini la investigaci\u00f3 amb la pr\u00e0ctica cl\u00ednica.<\/b><span style=\"font-weight: 400;\"> El projecte TRIP-Clinics s&#8217;ha impulsat amb el suport de la <\/span><b>Fundaci\u00f3 \u201dla Caixa\u201d<\/b><span style=\"font-weight: 400;\"> i el <\/span><b>Departament de Salut de la Generalitat de Catalunya.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">En aquesta primera convocat\u00f2ria, <\/span><b>la Fundaci\u00f3 \u201dla Caixa\u201d finan\u00e7a dos dels tres laboratoris que han estat constitu\u00efts amb 1,2 milions d&#8217;euros durant tres anys<\/b><span style=\"font-weight: 400;\">. Es tracta dels laboratoris formats per<\/span> <b><a href=\"https:\/\/caixaresearch.org\/ca\/convocatoria-caixaresearch-investigacio-salut-2018-projecte-cancer-mama\" target=\"_blank\" rel=\"noopener\">Dr. Roger Gomis<\/a>,<\/b><span style=\"font-weight: 400;\"> de l&#8217;IRB Barcelona, \u200b\u200bamb els <\/span><b>Dr. Aleix Prat<\/b><span style=\"font-weight: 400;\">,<\/span><b> la Dra. Laura Angelats <\/b><span style=\"font-weight: 400;\">i la <\/span><b>Dra. Sonia Guedan<\/b><span style=\"font-weight: 400;\">, de l\u2019IDIBAPS, i el del <\/span><b>Dr. Salvador Aznar Benitah<\/b><span style=\"font-weight: 400;\">, de l&#8217;IRB Barcelona, \u200b\u200bamb<\/span> <span style=\"font-weight: 400;\">la <\/span><a href=\"https:\/\/caixaresearch.org\/ca\/convocatoria-caixaimpulse-innovacio-salut-2023-projecte-cancer-llet-materna\" target=\"_blank\" rel=\"noopener\"><b>Dra. Cristina Saura <\/b><\/a><span style=\"font-weight: 400;\">i<\/span><b> la Dra. Isabel Pimentel<\/b><span style=\"font-weight: 400;\">, del Vall d&#8217;Hebron Institut d&#8217;Oncologia (VHIO).\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El Departament de Salut de la Generalitat de Catalunya subvenciona la part del sub programa TRIP Clinics que ha fer possible la creaci\u00f3 del laboratori format per la<\/span> <a href=\"https:\/\/becarios.fundacionlacaixa.org\/cristina-mayor-ruiz-B005352?doAsUserId=XZCK%2F8z8YaO31UHkguH%2Fuw==\" target=\"_blank\" rel=\"noopener\"><b>Dra. Cristina Mayor-Ruiz<\/b><\/a><span style=\"font-weight: 400;\">, de l&#8217;IRB Barcelona i el <\/span><a href=\"https:\/\/blog.caixaresearch.org\/ensayos-clinicos-vhio-tratamientos-cancer\/\" target=\"_blank\" rel=\"noopener\"><b>Dr. C\u00e9sar Serrano<\/b><\/a><span style=\"font-weight: 400;\">, del (VHIO). El 2021, la Cristina va rebre una <\/span><a href=\"https:\/\/fundacionlacaixa.org\/ca\/beques-postdoctorat-junior-leader\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">beca de postdoctorat Junior Leader<\/span><\/a><span style=\"font-weight: 400;\"> de la Fundaci\u00f3 \u201dla Caixa\u201d.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00abAquest projecte ens permetr\u00e0 <\/span><b>accelerar la translaci\u00f3 de la investigaci\u00f3 fonamental a la pr\u00e0ctica cl\u00ednica i que aix\u00ed pugui arribar abans a tenir un impacte a la societat. Unir grups de recerca fonamental i cl\u00ednica en un \u00fanic espai per abordar malalties complexes, com ho \u00e9s, per exemple, el c\u00e0ncer, suposa un canvi de paradigma respecte al que es feia fins ara<\/b><span style=\"font-weight: 400;\">\u00bb, afirma el <\/span><b>Dr. Francesc Posas<\/b><span style=\"font-weight: 400;\">, director de l&#8217;IRB Barcelona.<\/span><\/p>\n<div id=\"attachment_8072\" style=\"width: 410px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8072\" class=\"wp-image-8072\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg\" alt=\"\" width=\"400\" height=\"225\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg 2560w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-300x169.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-1024x576.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-768x432.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-1536x864.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><p id=\"caption-attachment-8072\" class=\"wp-caption-text\"><em>Francesc Posas, director de l\u2019IRB Barcelona<\/em><\/p><\/div>\n<p><b>El programa TRIP es divideix en dues grans l\u00ednies<\/b><span style=\"font-weight: 400;\">. D&#8217;una banda, el subprograma <\/span><b>TRIP \u2013 Clinics<\/b><span style=\"font-weight: 400;\"> es basa a <\/span><b>definir projectes de recerca conjunts entre investigadors de l&#8217;IRB Barcelona i professionals m\u00e8dics investigadors de qualsevol hospital de Catalunya.<\/b><span style=\"font-weight: 400;\"> D&#8217;aquesta manera es promouen la recerca fonamental i la cl\u00ednica en un mateix entorn, alhora que <\/span><b>es facilita l&#8217;acc\u00e9s conjunt als recursos de coneixement, tecnol\u00f2gics i aplicabilitat.<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><b>La proposta \u00e9s la primera d\u2019aquestes caracter\u00edstiques a Espanya i \u00e9s pionera a Europa<\/b><span style=\"font-weight: 400;\">. El resultat final que s\u2019espera d\u2019aquesta integraci\u00f3 \u00e9s desenvolupar <\/span><b>noves eines diagn\u00f2stiques i terap\u00e8utiques o millorar-ne les existents, la qual cosa pot derivar en noves patents, formaci\u00f3 d\u2019empreses de base biotecnol\u00f2gica o llic\u00e8ncia de productes.<\/b><\/p>\n<p><b>La segona l\u00ednia del programa contempla la incorporaci\u00f3 de l\u00edders de grup j\u00fanior per iniciar nous laboratoris centrats en \u00e0rees estrat\u00e8giques emergents (subprograma TRIP \u2013 Preclinical).<\/b><span style=\"font-weight: 400;\"> Els caps de laboratori s\u00f3n seleccionats per un comit\u00e8 internacional. Els investigadors que recentment han obert un laboratori a l&#8217;IRB Barcelona en el marc del programa TRIP. S\u00f3n la <\/span><a href=\"https:\/\/becarios.fundacionlacaixa.org\/stefanie-k-wculek--B005113?nav=true\" target=\"_blank\" rel=\"noopener\"><b>Dra. Stefanie Wculek<\/b><\/a><span style=\"font-weight: 400;\">, qui lidera un laboratori en immunologia i que s&#8217;hi ha incorporat tamb\u00e9 gr\u00e0cies al suport de 900.000 euros de la Fundaci\u00f3 \u201dla Caixa\u201d, la <\/span><a href=\"https:\/\/becarios.fundacionlacaixa.org\/direna-alonso-curbelo-B005081?doAsUserId=7dQxmoMJH6TFmU%2BfTuKpGg==\" target=\"_blank\" rel=\"noopener\"><b>Dra. Direna Alonso-Curbelo<\/b><\/a><span style=\"font-weight: 400;\">, que investiga la inflamaci\u00f3 i la seva relaci\u00f3 amb el c\u00e0ncer i l&#8217;envelliment, i el <\/span><a href=\"https:\/\/becarios.fundacionlacaixa.org\/alejo-rodriguez-fraticelli-B002468?doAsUserId=If8dE1uy4yqCtt%2B6zCPmdQ==\" target=\"_blank\" rel=\"noopener\"><b>Dr. Alejo Rodriguez-Fraticelli<\/b><\/a><span style=\"font-weight: 400;\">, qui centra els seus estudis en l&#8217;epigen\u00f2mica i el tra\u00e7at de llinatges cel\u00b7lulars. Tots tres van gaudir d\u2019una beca de postdoctorat Junior Leader entre 2020 i 2021.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Aquestes \u00e0rees s\u00f3n considerades priorit\u00e0ries i es podrien definir com a n\u00ednxols d&#8217;oportunitat cient\u00edfics.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">L\u2019objectiu dels diferents laboratoris del subprograma TRIP &#8211; Clinics s\u00f3n els seg\u00fcents: <\/span><\/p>\n<p><b><i>C\u00e0ncer de mama metast\u00e0tic<\/i><\/b><\/p>\n<p><span style=\"font-weight: 400;\">El c\u00e0ncer de mama pot ser mortal si es dissemina altres \u00f2rgans, especialment si s&#8217;associa amb resist\u00e8ncia als medicaments. Tot i resultar sorprenent, la majoria de les met\u00e0stasis en \u00f2rgans distants no s\u00f3n causades per les c\u00e8l\u00b7lules del tumor primari, sin\u00f3 que passen per una etapa pr\u00e8via als ossos, on adquireixen resist\u00e8ncia al tractament, abans d&#8217;expandir-se.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El laboratori que codirigiran l&#8217;investigador ICREA<\/span> <b>Dr. Roger Gomis<\/b><span style=\"font-weight: 400;\">,<\/span> <span style=\"font-weight: 400;\">cap del laboratori Control del Creixement i Met\u00e0stasi del C\u00e0ncer de l&#8217;IRB Barcelona, \u200b\u200bjuntament amb la <\/span><b>Dra. Laura Angelats <\/b><span style=\"font-weight: 400;\">i la<\/span><b> Dra. Sonia Guedan<\/b><span style=\"font-weight: 400;\">, de l&#8217;IDIBAPS, intentar\u00e0 aclarir aquest proc\u00e9s, que no es pot explicar completament pels canvis a l&#8217;ADN de les c\u00e8l\u00b7lules tumorals metast\u00e0siques, sin\u00f3 que requereix una adaptaci\u00f3 m\u00e9s din\u00e0mica als seus entorns canviants.<\/span><\/p>\n<div id=\"attachment_8062\" style=\"width: 410px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8062\" class=\"wp-image-8062\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_21-scaled.jpg\" alt=\"\" width=\"400\" height=\"225\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_21-scaled.jpg 2560w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_21-300x169.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_21-1024x576.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_21-768x432.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_21-1536x864.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_21-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><p id=\"caption-attachment-8062\" class=\"wp-caption-text\"><em>Roger Gomis, IRB Barcelona<\/em><\/p><\/div>\n<p><b>\u00abEl nostre objectiu \u00e9s definir i comprendre a nivell molecular aquesta plasticitat de c\u00e8l\u00b7lules de c\u00e0ncer de mama, pr\u00e8viament subestimada<\/b><span style=\"font-weight: 400;\">. Per qu\u00e8 i com la resist\u00e8ncia al tractament est\u00e0ndard permet que les c\u00e8l\u00b7lules tumorals del c\u00e0ncer de mama es propaguin a altres \u00f2rgans? Creiem que identificant la base de la disseminaci\u00f3 multiorg\u00e0nica adaptativa podrem prevenir o revertir la met\u00e0stasi del c\u00e0ncer de mama terminal\u00bb, explica el <\/span><b>Dr. Gomis<\/b><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<div id=\"attachment_8060\" style=\"width: 410px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8060\" class=\"wp-image-8060\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_20-scaled.jpg\" alt=\"\" width=\"400\" height=\"225\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_20-scaled.jpg 2560w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_20-300x169.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_20-1024x576.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_20-768x432.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_20-1536x864.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_20-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><p id=\"caption-attachment-8060\" class=\"wp-caption-text\"><em>Laura Angelats, IDIBAPS, Barcelona<\/em><\/p><\/div>\n<p><span style=\"font-weight: 400;\">Els investigadors faran servir<\/span><b> t\u00e8cniques d&#8217;enginyeria gen\u00e8tica per modificar les c\u00e8l\u00b7lules immunit\u00e0ries dels pacients perqu\u00e8 puguin recon\u00e8ixer i eliminar aquestes c\u00e8l\u00b7lules de c\u00e0ncer de mama resistents als medicaments<\/b><span style=\"font-weight: 400;\">. Aquest tipus de ter\u00e0pia, coneguda com a CAR-T, ha revolucionat el tractament dels c\u00e0ncers hematol\u00f2gics. L&#8217;objectiu en aquest projecte <\/span><b>ser\u00e0 traduir el poder de la ter\u00e0pia CAR-T al tractament del c\u00e0ncer de mama i obtenir aix\u00ed una opci\u00f3 terap\u00e8utica nova per a pacients amb c\u00e0ncer de mama incurable.<\/b><\/p>\n<div id=\"attachment_8044\" style=\"width: 410px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8044\" class=\"wp-image-8044\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_23-scaled.jpg\" alt=\"\" width=\"400\" height=\"225\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_23-scaled.jpg 2560w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_23-300x169.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_23-1024x576.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_23-768x432.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_23-1536x864.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_23-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><p id=\"caption-attachment-8044\" class=\"wp-caption-text\"><em>Sonia Guedan, IDIBAPS, Barcelona<\/em><\/p><\/div>\n<p><b><i>Un nou enfocament per tractar els sarcomes del tracte gastrointestinal<\/i><\/b><\/p>\n<p><span style=\"font-weight: 400;\">Molts tipus de tumors es caracteritzen pel funcionament an\u00f2mal de prote\u00efnes de la membrana cel\u00b7lular (Receptor Tyrosine Kinases o RTKs, per les sigles en angl\u00e8s). Hi ha tractaments per a aquest tipus de c\u00e0ncers que es basen en f\u00e0rmacs inhibidors de RTKs. <\/span><b>Aquests inhibidors proporcionen un benefici cl\u00ednic significatiu a curt termini, per\u00f2 la gran majoria dels pacients desenvolupa resist\u00e8ncia a aquests tractaments a mitj\u00e0-llarg termini.\u00a0<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Davant aquesta necessitat cl\u00ednica, la <\/span><b>Dra. Cristina Mayor-Ruiz<\/b><span style=\"font-weight: 400;\">, cap del laboratori de Degradaci\u00f3 Dirigida de Prote\u00efnes i Descobriment de F\u00e0rmacs de l&#8217;IRB Barcelona, \u200b\u200bi el <\/span><b>Dr. C\u00e9sar Serrano<\/b><span style=\"font-weight: 400;\">, cap del grup de Recerca Traslacional a Sarcomes del VHIO, han posat en marxa un projecte per <\/span><b>trobar ter\u00e0pies alternatives, centrant-se en primer lloc en sarcomes del tracte gastrointestinal.<\/b><\/p>\n<div id=\"attachment_8052\" style=\"width: 410px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8052\" class=\"wp-image-8052\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_16-scaled.jpg\" alt=\"\" width=\"400\" height=\"225\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_16-scaled.jpg 2560w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_16-300x169.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_16-1024x576.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_16-768x432.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_16-1536x864.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_16-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><p id=\"caption-attachment-8052\" class=\"wp-caption-text\"><em>Cristina Mayor-Ruiz, IRB Barcelona<\/em><\/p><\/div>\n<p><b>La degradaci\u00f3 dirigida de prote\u00efnes \u00e9s una nova estrat\u00e8gia farmacol\u00f2gica que fa \u00fas del proc\u00e9s pel qual les c\u00e8l\u00b7lules marquen espec\u00edficament prote\u00efnes indesitjables o no funcionals per a la seva destrucci\u00f3 a la &#8220;trituradora de prote\u00efnes&#8221; anomenada \u201cproteasoma\u201d.<\/b><span style=\"font-weight: 400;\"> L&#8217;equip investigador explorar\u00e0 el potencial dels f\u00e0rmacs degradadors per provocar l&#8217;eliminaci\u00f3 de prote\u00efnes rellevants com a diana terap\u00e8utica contra els sarcomes gastrointestinals.<\/span><\/p>\n<p>&nbsp;<\/p>\n<div id=\"attachment_8050\" style=\"width: 410px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8050\" class=\"wp-image-8050\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_15-scaled.jpg\" alt=\"\" width=\"400\" height=\"225\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_15-scaled.jpg 2560w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_15-300x169.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_15-1024x576.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_15-768x432.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_15-1536x864.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_15-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><p id=\"caption-attachment-8050\" class=\"wp-caption-text\"><em>C\u00e9sar Serrano, VHIO, Barcelona<\/em><\/p><\/div>\n<p><span style=\"font-weight: 400;\">\u00abLa degradaci\u00f3 dirigida de prote\u00efnes ens ofereix una alternativa per atacar aquests tipus de tumors dependents de RTKs sense que es desenvolupin resist\u00e8ncies. <\/span><b>Mitjan\u00e7ant un enfocament de cribratge de f\u00e0rmacs sistem\u00e0tic, esperem trobar candidats prometedors\u00bb, explica la Dra. Mayor-Ruiz. El projecte contempla l&#8217;avaluaci\u00f3 dels candidats a f\u00e0rmacs a nous models cel\u00b7lulars i animals desenvolupats pel grup. Les noves mol\u00e8cules seran testades precl\u00ednicament i podrien establir les bases per a futurs a assaigs cl\u00ednics en humans.<\/b><\/p>\n<p><b><i>El metabolisme de la met\u00e0stasi<\/i><\/b><\/p>\n<p><span style=\"font-weight: 400;\">Les c\u00e8l\u00b7lules cancer\u00edgenes es reprodueixen a gran velocitat i consumeixen nivells elevats de sucre. Tot i aix\u00f2, <\/span><b>les c\u00e8l\u00b7lules metast\u00e0tiques, \u00e9s a dir, les que tenen la capacitat d&#8217;escapar del tumor primari i colonitzar altres \u00f2rgans del cos, obtenen l&#8217;energia del metabolisme dels greixos, principalment de l&#8217;\u00e0cid palm\u00edtic.\u00a0<\/b><\/p>\n<p><span style=\"font-weight: 400;\">El projecte que han empr\u00e8s el <\/span><b>Dr. Salvador Aznar Benitah<\/b><span style=\"font-weight: 400;\">, cap del laboratori de C\u00e8l\u00b7lules Mare i C\u00e0ncer de l&#8217;IRB Barcelona, juntament amb la <\/span><b>Dra. Cristina Saura<\/b><span style=\"font-weight: 400;\"> i la <\/span><b>Dra. Isabel Pimentel<\/b><span style=\"font-weight: 400;\"> del VHIO considera una nova manera de combatre els tumors metast\u00e0sics: bloquejant directament la seva font d&#8217;energia.<\/span><\/p>\n<div id=\"attachment_8064\" style=\"width: 410px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8064\" class=\"wp-image-8064\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_22-scaled.jpg\" alt=\"\" width=\"400\" height=\"225\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_22-scaled.jpg 2560w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_22-300x169.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_22-1024x576.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_22-768x432.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_22-1536x864.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_22-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><p id=\"caption-attachment-8064\" class=\"wp-caption-text\"><em>Salvador Aznar Benitah, IRB Barcelona<\/em><\/p><\/div>\n<p><span style=\"font-weight: 400;\">\u00abUna de les malalties metast\u00e0siques m\u00e9s urgents a abordar \u00e9s el c\u00e0ncer de mama triple negatiu metast\u00e0tic, que sovint no respon al tractament i t\u00e9 molt mal pron\u00f2stic. Un problema important \u00e9s que <\/span><b>la malaltia t\u00e9 diferents bases biol\u00f2giques que varien entre les diferents pacients, i aix\u00f2 complica la recerca de tractaments adequats\u00bb<\/b><span style=\"font-weight: 400;\">, explica el <\/span><b>Dr. Aznar Benitah<\/b><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<div id=\"attachment_8054\" style=\"width: 410px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8054\" class=\"wp-image-8054\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_17-scaled.jpg\" alt=\"\" width=\"400\" height=\"225\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_17-scaled.jpg 2560w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_17-300x169.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_17-1024x576.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_17-768x432.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_17-1536x864.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_17-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><p id=\"caption-attachment-8054\" class=\"wp-caption-text\">Cristina Saura, VHIO, Barcelona<\/p><\/div>\n<p><span style=\"font-weight: 400;\">L&#8217;equip cient\u00edfic investigar\u00e0 la relaci\u00f3 entre les c\u00e8l\u00b7lules tumorals metast\u00e0siques i les c\u00e8l\u00b7lules de Schwann, que corrompen el metabolisme del teixit al voltant del tumor en benefici d&#8217;aquest.<\/span><b> L&#8217;objectiu general del projecte \u00e9s determinar en el moment del diagn\u00f2stic quins pacients amb c\u00e0ncer de mama triple negatiu podrien beneficiar-se d&#8217;una immunoter\u00e0pia nova basada en la reprogramaci\u00f3 metab\u00f2lica immunit\u00e0ria en lloc de (o a m\u00e9s de) els inhibidors convencionals<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<div id=\"attachment_8058\" style=\"width: 410px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8058\" class=\"wp-image-8058\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_19-scaled.jpg\" alt=\"\" width=\"400\" height=\"225\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_19-scaled.jpg 2560w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_19-300x169.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_19-1024x576.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_19-768x432.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_19-1536x864.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_19-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><p id=\"caption-attachment-8058\" class=\"wp-caption-text\"><em>Isabel Pimentel, VHIO, Barcelona<\/em><\/p><\/div>\n<p><span style=\"font-weight: 400;\">[Aquest text s\u2019ha extret de la <\/span><a href=\"https:\/\/mediahub.fundacionlacaixa.org\/ca\/investigacio-salut\/salut\/investigacio-cientifica\/2024-03-06\/neix-programa-pioner-europa-investigacio-translacional-5628.html\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">nota de premsa<\/span><\/a><span style=\"font-weight: 400;\"> de l\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Barcelona (IRBB).]<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p><iframe loading=\"lazy\" title=\"Programa TRIP | Con la colaboraci\u00f3n de Fundaci\u00f3n &quot;la Caixa&quot;\" src=\"https:\/\/www.youtube.com\/embed\/ZN-J6WHYS8Y\" width=\"400\" height=\"225\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>Un dels problemes de major complexitat en la investigaci\u00f3 biom\u00e8dica internacional \u00e9s com traslladar el coneixement generat als centres de recerca a la pr\u00e0ctica cl\u00ednica, i viceversa, de la forma m\u00e9s eficient i en el menor temps possible. Aquest proc\u00e9s, conegut com a \u201cinvestigaci\u00f3 translacional\u201d, s&#8217;ha assajat a tot el m\u00f3n amb f\u00f3rmules diverses, entre les quals s\u2019inclou empla\u00e7ar centres de recerca fonamental a hospitals per propiciar el contacte entre tots dos \u00e0mbits i el desenvolupament de projectes conjunts.<\/p>\n<p>La innovadora proposta de l&#8217;IRB Barcelona, en el marc del <a href=\"https:\/\/www.irbbarcelona.org\/ca\/about-us\/projects-alliances\/translational-research-and-innovation-programme-trip\" target=\"_blank\" rel=\"noopener\">programa pilot TRIP (en angl\u00e8s, <i>Translational Research Innovation Programme<\/i>)<\/a>, resideix en promocionar grups de recerca que estiguin liderats per,<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[340],"tags":[],"class_list":["post-8075","post","type-post","status-publish","format-standard","hentry","category-sense-categoria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Un programa pioner a Europa per acelerar la traslaci\u00f3 de la investigaci\u00f3 a la pr\u00e0ctica cl\u00ednica - Blog CaixaCi\u00e8ncia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un programa pioner a Europa per acelerar la traslaci\u00f3 de la investigaci\u00f3 a la pr\u00e0ctica cl\u00ednica - Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"og:description\" content=\"Un dels problemes de major complexitat en la investigaci\u00f3 biom\u00e8dica internacional \u00e9s com traslladar el coneixement generat als centres de recerca a la pr\u00e0ctica cl\u00ednica, i viceversa, de la forma m\u00e9s eficient i en el menor temps possible. Aquest proc\u00e9s, conegut com a \u201cinvestigaci\u00f3 translacional\u201d, s&#8217;ha assajat a tot el m\u00f3n amb f\u00f3rmules diverses, entre les quals s\u2019inclou empla\u00e7ar centres de recerca fonamental a hospitals per propiciar el contacte entre tots dos \u00e0mbits i el desenvolupament de projectes conjunts. La innovadora proposta de l&#8217;IRB Barcelona, en el marc del programa pilot TRIP (en angl\u00e8s, Translational Research Innovation Programme), resideix en promocionar grups de recerca que estiguin liderats per,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-06T10:08:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-06T10:56:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg\" \/>\n<meta name=\"author\" content=\"Ubikmedia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ubikmedia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/\",\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/\",\"name\":\"Un programa pioner a Europa per acelerar la traslaci\u00f3 de la investigaci\u00f3 a la pr\u00e0ctica cl\u00ednica - Blog CaixaCi\u00e8ncia\",\"isPartOf\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg\",\"datePublished\":\"2024-03-06T10:08:12+00:00\",\"dateModified\":\"2024-03-06T10:56:25+00:00\",\"author\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/#primaryimage\",\"url\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg\",\"contentUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\",\"url\":\"https:\/\/blog.caixaresearch.org\/\",\"name\":\"Blog CaixaCi\u00e8ncia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.caixaresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\",\"name\":\"Ubikmedia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"caption\":\"Ubikmedia\"},\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un programa pioner a Europa per acelerar la traslaci\u00f3 de la investigaci\u00f3 a la pr\u00e0ctica cl\u00ednica - Blog CaixaCi\u00e8ncia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/","og_locale":"ca_ES","og_type":"article","og_title":"Un programa pioner a Europa per acelerar la traslaci\u00f3 de la investigaci\u00f3 a la pr\u00e0ctica cl\u00ednica - Blog CaixaCi\u00e8ncia","og_description":"Un dels problemes de major complexitat en la investigaci\u00f3 biom\u00e8dica internacional \u00e9s com traslladar el coneixement generat als centres de recerca a la pr\u00e0ctica cl\u00ednica, i viceversa, de la forma m\u00e9s eficient i en el menor temps possible. Aquest proc\u00e9s, conegut com a \u201cinvestigaci\u00f3 translacional\u201d, s&#8217;ha assajat a tot el m\u00f3n amb f\u00f3rmules diverses, entre les quals s\u2019inclou empla\u00e7ar centres de recerca fonamental a hospitals per propiciar el contacte entre tots dos \u00e0mbits i el desenvolupament de projectes conjunts. La innovadora proposta de l&#8217;IRB Barcelona, en el marc del programa pilot TRIP (en angl\u00e8s, Translational Research Innovation Programme), resideix en promocionar grups de recerca que estiguin liderats per,","og_url":"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/","og_site_name":"Blog CaixaCi\u00e8ncia","article_published_time":"2024-03-06T10:08:12+00:00","article_modified_time":"2024-03-06T10:56:25+00:00","og_image":[{"url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg","type":"","width":"","height":""}],"author":"Ubikmedia","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Ubikmedia","Temps estimat de lectura":"9 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/","url":"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/","name":"Un programa pioner a Europa per acelerar la traslaci\u00f3 de la investigaci\u00f3 a la pr\u00e0ctica cl\u00ednica - Blog CaixaCi\u00e8ncia","isPartOf":{"@id":"https:\/\/blog.caixaresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/#primaryimage"},"image":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg","datePublished":"2024-03-06T10:08:12+00:00","dateModified":"2024-03-06T10:56:25+00:00","author":{"@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/ca\/programa-pioner-europa-acelerar-traslacio-investigacio-trip\/#primaryimage","url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg","contentUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2024\/03\/CR_TRIP-Ndp_28-scaled.jpg"},{"@type":"WebSite","@id":"https:\/\/blog.caixaresearch.org\/#website","url":"https:\/\/blog.caixaresearch.org\/","name":"Blog CaixaCi\u00e8ncia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.caixaresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca","name":"Ubikmedia","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","caption":"Ubikmedia"},"url":"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/8075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/comments?post=8075"}],"version-history":[{"count":8,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/8075\/revisions"}],"predecessor-version":[{"id":8087,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/8075\/revisions\/8087"}],"wp:attachment":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/media?parent=8075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/categories?post=8075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/tags?post=8075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}